Trial Profile
Imaging of Osteonecrosis With Ferumoxytol-Enhanced MRI
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 19 May 2023
Price :
$35
*
At a glance
- Drugs Ferumoxytol (Primary)
- Indications Osteonecrosis
- Focus Diagnostic use; Proof of concept
- Acronyms Osteonecro
- 15 May 2023 Planned End Date changed from 1 Oct 2022 to 1 Dec 2023.
- 15 May 2023 Planned primary completion date changed from 1 Oct 2022 to 1 Oct 2023.
- 22 Aug 2022 Planned End Date changed from 1 Jan 2022 to 1 Oct 2022.